R Galib
Gujarat Ayurved University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by R Galib.
Toxicology International | 2014
Chandrashekhar Y Jagtap; Swapnil Y Chaudhari; Jalaram H Thakkar; R Galib; Pk Prajapati
Objectives: Herbo-mineral formulations are being successfully used in therapeutics since centuries. But recently, they came under the scanner for their metallic contents especially the presence of heavy metals. Hence it is the need of the hour to assess and establish the safety of these formulations through toxicity studies. In line with the various toxicity studies that are being carried out, Government of India expressed the need for conducting genotoxicity studies of different metal- or mineral-based drugs. Till date very few Ayurvedic herbo-mineral formulations have been studied for their genotoxic potential. The present study is aimed to evaluate the genotoxic potential of Hridayarnava Rasa. Materials and Methods: It was prepared as per classical guidelines and administered to Swiss albino mice for 14 consecutive days. Chromosomal aberration and sperm abnormality assay were done to evaluate the genotoxic potential of the test drugs. Cyclophosphamide (CP) was taken as positive group and results were compared. Results: All treated groups exhibited significant body weight gain in comparison to CP group. Results revealed no structural deformity in the above parameters in comparison to the CP-treated group. Conclusion: Reported data showed that both tested samples of Hridayarnava Rasa does not possess genotoxic potential under the experimental conditions and can be safely used.
Ayu (an International Quarterly Journal of Research in Ayurveda) | 2013
Rohit Sharma; Vijay Kumar; Bk Ashok; R Galib; Pradeep Kumar Prajapati; B Ravishankar
Over the centuries, herbs have served as a major source of medicines for prevention and treatment of diseases including diabetes mellitus. These herbs are getting more importance around the globe and many studies have provided safety and efficacy of such herbal drugs in different condition. Guduchi (Tinospora cordifolia [Willd.] Miers) is reported as highly potent Pramehahara (anti-diabetic) herb in Ayurveda and Guduchi Satva (GS) is popularly used to treat Paittika type of Prameha. In the present study, GS prepared from the stem of T. cordifolia was evaluated for hypoglycemic and anti-hyperglycemic activity in 18 h fasted mice. GS was suspended in distilled water and administered to animals at the dose of 130 mg/kg that showed the marginal reduction in blood sugar level (BSL) at all the time intervals in normoglycemic mice. In anti-hyperglycemic activity, administration of GS prior to glucose over load failed to attenuate BSL at all-time interval in comparison to glucose control group. The study concludes that mild hypoglycemic insignificant anti-hyperglycemic activities of GS.
Ayu (an International Quarterly Journal of Research in Ayurveda) | 2013
Mayur Mashru; R Galib; Vinay J Shukla; B Ravishankar; Pradeep Kumar Prajapati
Asthma represents a profound world-wide public health problem. The most effective anti-asthmatic drugs currently available include β2-agonists and glucocorticoids which can controls asthma in about 90-95% of patients. In Ayurveda, this miserable condition is comparable with Tamaka Shwasa type of Shwasa Roga. In the present study, 52 patients were treated with Sameera Pannaga Rasa at a dose of 30 mg twice a day for 4 weeks along with Nagavallidala (leaf of Piper betel Linn.) The results were assessed in terms of clinical recovery, symptomatic relief, pulmonary function improvement and on subjective and objective parameters. A significant improvement in subjective parameters, control on asthma, recurrence of asthma, increase in peak expiratory flow rate, considerable decrease in total and absolute, acute eosinophil count and erythrocyte sedimentation rate were observed. Overall marked improvement was found in 33.33%, moderate improvement in 44.44% and mild improvement in 20.00% was observed. The study reveals that Sameera Pannaga Rasa can be used as an effective drug in bronchial asthma.
Ancient Science of Life | 2015
Kruti Yagneshkumar Vyas; Prashant Bedarkar; R Galib; Pradeep Kumar Prajapati
Objective: Guggulu (Commiphora wightii [Arn.] Bhandari) is a well-known anti-hyperlipidaemic drug. Guggulsterones are active components of this drug which are responsible for this effect. The activity of Guggulu may depend upon its nature, fresh samples are recommended for their bṛhmaṇa (body mass increasing) effect; while lekhana (scarificant) effect is attributed to the old one. The comparative Anti-hyperlipidaemic activity of fresh and old samples has not been reported till date. Materials and Methods: Freshly collected and one year old samples of Guggulu were processed in gomūtra. Patients who satisfied inclusion criteria of Hyperlipidaemia were randomly distributed into two groups and the drug was administrated in a dose of 1 g with luke warm water twice a day for eight weeks. Results: Significant improvement was found in the symptoms of Medoroga and Lipid profile with treatment in both the groups. Fresh sample of Guggulu proved to have a better effect in lowering serum cholesterol (5.76%), triglyceride (17.17%), and very low density lipoprotein VLDL (18.36%) levels while old sample of Guggulu provided mild effect in lowering serum triglyceride (13.64%), VLDL (11.07%) and non-significant increase in serum HDL-cholesterol (0.94%). Old sample of Guggulu also provided significant decreases in body weight (7.69%) and BMI (7.82%). Conclusions: Old Guggulu showed better effect on body weight, BMI and cardinal symptoms along with significant lipid lowering effect whereas fresh Guggulu showed better result on lipid profile.
Journal of Ayurveda and Integrative Medicine | 2016
Swapnil Y Chaudhari; Mukesh B Nariya; R Galib; Pradeep Kumar Prajapati
Background Tamra Bhasma (TB) is one among herbo-metallic preparations extensively used in routine ayurvedic practice. In the present era, Bhasma preparations used in ayurvedic system of medicines are always under stern observations for containing heavy metals which may raise the question of safety aspect. Objective In the present study, TB prepared with and without Amritikarana was subjected to toxicity study to ascertain the role of Amritikarana on safety profile of TB in rats. Materials and methods Both the samples of TB were administered to rats for 28 consecutive days at the doses of 5.5, 27.5, and 55 mg/kg. The effects of both drugs were assessed on ponderal changes, hematological, serum biochemical, and histopathology of various organs. Results Results showed that both the samples of TB did not produce any sign and symptoms of toxicity at therapeutic dose level (5.5 mg/kg) and therapeutic equivalent dose (TED) × 5 (27.5 mg/kg) while at higher dose of TED × 10 (55 mg/kg) TB has mild toxicity in liver, kidney, heart, and thymus on repeated administration for 28 days in rats. The sample without Amritikarana has more magnitude of toxicity than the sample with Amritikarana. Conclusion From the present study, it is concluded that TB with Amritikarana was found to be relatively safer than TB without Amritikarana at different dose levels in rats and hence suggest for safely use in humans at therapeutic dose level. It proves the role of Amritikarana in the preparation of TB.
Journal of Ayurveda and Integrative Medicine | 2015
Hasmukh R Jadav; R Galib; Pradeep Kumar Prajapati
Standardization of herbal drugs is essential to certify their quality and purity. Kshara (alkaline substance) of Apamarga (Achyranthes aspera Linn.) is an important constituent in many Ayurvedic formulations, but its standard manufacturing process (SMP) is not attempted till date. This study is aimed to establish SMP for Apamarga kshara. In pharmaceutical process; generally the sediments of ash obtained at the end of washes will be discarded. However, in the study, we attempted to wash the sediments repeatedly by adding water to extract more Kshara. Apamarga was collected from the local area and authenticated. Kshara was prepared by following standard methods and the preliminary physicochemical profile was developed. It is observed that the ash yields Kshara even in the consecutive washes. First wash yielded 21.23% w/w Kshara, while the second and third washes yielded 9.38% w/w and 4.76% w/w, respectively. Repeated washes yield more Kshara. Hence, it is advocated to wash the ashes repeatedly. As the findings are encouraging, similar experiments can be extended to all other Kshara preparations.
Ayu (an International Quarterly Journal of Research in Ayurveda) | 2015
Swapnil Y Chaudhari; Dhirajsingh Sumersingh Rajput; R Galib; Pradeep Kumar Prajapati
Introduction:Tamra Bhasma, one among the herbo-metallic preparations is extensively used in Ayurveda for different conditions. To make it safe to use, Tamra has to pass through a set of classical pharmaceutical procedures including a series of quenching in prescribed liquids, followed by incineration with black sulfide of mercury and herbal juice of Citrus jambhiri Lush. and corm of Amorphophallus campanulatus Linn. FTIR profiles of Tamra Bhasma at different levels is not available. Aim: To evaluate the chemical changes in Tamra Bhasma at different steps by following Fourier transform infrared (FTIR) spectroscopy.Materials and Methods: In current study, raw Tamra, intermediate samples obtained during purification, incineration and Amritikarana were analyzed using FTIR. Results: It was observed that Shodhana procedure leads in the formation of bonds between surface particles of Tamra and Shodhana media. These formed bonds on the surface of Shodhita Tamra samples gave various sharp peaks representing presence of many functional groups. Conclusion: The FTIR spectra revealed that both Bhasma samples contained organic compounds probably in the form of a complex with common functional groups like alkyl, methyl, etc., which need further studies for exact characterization of the complexes.
Ayu (an International Quarterly Journal of Research in Ayurveda) | 2015
Ankit Mansukhbhai Paneliya; Bj Patgiri; R Galib; Pradeep Kumar Prajapati
Introduction: Bronchial asthma is one of the chronic inflammatory disorders of the respiratory tract causing a huge number of deaths annually. Increased industrialization and pollution are the exacerbating factors for this situation. In Ayurveda, this miserable condition is comparable with Tamaka Shwasa. Synthetic drugs provide instant symptomatic relief in cases of bronchial asthma but are known to develop certain adverse drug reactions. Considering this, the current suffering population is looking hopefully towards other systems of medicine such as Ayurveda for better relief. Ayurveda has a number of formulations to treat Tamaka Shwasa and is in practice with proven efficacy. Aims: To evaluate comparative clinical efficacy of Vasa Avaleha (VA) and its granules (GVA) in cases of Tamaka Shwasa. Materials and Methods: A total of 66 patients were registered and randomly grouped into A and B. Patients of Group A were treated with VA, while Group B with GVA at dose of 6 g twice a day with lukewarm water for the duration of 28 days. Follow-up was done after 14 days. The results were assessed in terms of clinical recovery, symptomatic relief, and pulmonary function improvement. Effect of the treatment was assessed based on subjective and objective parameters. Results: Significant improvement was observed in most of the cardinal and associated symptoms. Significant increase in peak expiratory flow rate, considerable decrease in absolute eosinophil count, and increased breath holding time were noticed. Withdrawal of modern emergency drugs, decreased frequency of attacks, improved quality of life were the major observations noticed in both groups. Conclusions: This study highlights the significance of traditional herbal formulations in noncommunicable diseases such as bronchial asthma, which can be used as an effective drug in place or along with modern drugs.
International Journal of Green Pharmacy | 2013
Rohit Sharma; Vijay Kumar; Bk Ashok; R Galib; Pk Prajapati; B. Ravishankar
Background: Diabetes mellitus is a common endocrine disorder, characterized by hyperglycaemia resulting from defects in insulin secretion, insulin action or both. Ayurvedic herbs are relatively low cost, more suitable and have negligible side‑effects than synthetic oral anti‑hyperglycaemic agents. Guduchi is reported as highly potent anti‑diabetic herb in Ayurveda and Guduchi Ghanavati is popularly known by the Ayurvedic fraternity for its therapeutic properties on Madhumeha represented as diabetes mellitus. Aim: The aim of this study is to evaluate hypoglycaemic and anti‑hyperglycaemic activities of Guduchi Ghana (GG) in Swiss albino mice. Materials and Methods: Hypoglycaemic and anti‑hyperglycaemic potential of GG was evaluated in normal mice using both 18 h fasted mice model and oral glucose tolerance test. GG was suspended in distilled water and administered to animals at the dose of 130 mg/kg. Statistical Analysis: The results were statistically interpreted using Student’s ‘t’‑test for paired and unpaired data to assess the statistical significance and the significant level was set at P < 0.05. Results: GG showed mild reduction in blood sugar level (BSL) at all the time intervals in normoglycaemic mice. In anti‑hyperglycaemic activity, glibenclamide at a dose of 0.65 mg/kg studied as the reference standard to compare the potency of test drug. Administration of GG prior to glucose over load resulted significant attenuation in BSL at 60 min, 90 min and 120 min in comparison to glucose control group. Conclusions: GG has mild hypoglycaemic and significant anti‑hyperglycaemic activity and can be used in the treatment of diabetes mellitus as well as a supportive drug without fear of producing hypoglycaemia. Key words: Anti‑hyperglycaemic, Ghana, glibenclamide, Guduchi, hypoglycaemic, tinospora cordifolia
Ayu (an International Quarterly Journal of Research in Ayurveda) | 2013
Swapnil Y Chaudhari; Chandrashekhar Y Jagtap; R Galib; Prashant Bedarkar; Bj Patgiri; Pradeep Kumar Prajapati
The metal, Tamra though mentioned in Ayurveda with a wide range of therapeutic utilities; is attributed with Ashta Maha Dosha. Hence, one should be cautious while using Tamra Bhasma. Considering the significance of Tamra in therapeutics, many studies have been carried out at different centers of India. Aim of the present study was to compile such available research works done on Tamra in the Department of Rasa Shastra and Bhaishajya Kalpana (RS and BK), IPGT and RA, Jamnagar and provide brief information about pharmaceutical, analytical, and pharmacological studies. Total eleven studies on Tamra Bhasma, which revalidated the impact of classical guidelines, safety issues, and therapeutic utilities, were screened from PG Department of RS and BK, Institute for Post-Graduate Teaching and Research in Ayurveda, Gujarat Ayurved University, Jamnagar. All studies revealed that Tamra Bhasma is safe clinically, experimentally at Therapeutic Equivalent Dose (TED) levels as no toxic hazards were reported during the treatment period. In all aspects (pharmaceutical, pharmacological, and clinical) Somnathi Tamra Bhasma has proven to be better than Tamra Bhasma. The clinical efficacy of Tamra Bhasma has been evaluated in Shvasa, Kasa, Yakrit Pliha Vriddhi, Grahani, etc. conditions. Satisfactory responses with a decrease in the intensity of signs and symptoms were reported in all the studies. Though certain limitations were observed in these researches, the results can be considered as a lead for further well stratified studies covering larger population. No adverse effects were reported in any of these studies.